GYRE THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Gyre Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q2 2024.
  • Gyre Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 85.5M shares, a 34.5% increase year-over-year.
  • Gyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 65.8M shares, a 3.53% increase from 2022.
  • Gyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 63.6M shares, a 108% increase from 2021.
  • Gyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 30.6M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 85.5M +21.9M +34.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 83.3M +19.7M +30.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 65.8M +2.24M +3.53% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 38M +6.49M +20.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 63.6M +32.1M +102% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 63.6M +32.1M +102% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 63.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 31.5M +105K +0.33% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 31.5M +128K +0.41% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 31.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 31.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 31.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q3 2013 33.6M +150K +0.45% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-06
Q2 2013 33.6M +218K +0.65% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-07
Q1 2013 33.6M +226K +0.68% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-08
Q4 2012 33.6M +227K +0.68% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 33.5M +116K +0.35% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 33.4M +2.68M +8.74% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 33.4M +4.39M +15.2% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 33.4M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 33.4M +4.76M +16.6% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 30.7M +2.22M +7.77% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 29M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 28.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 28.5M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.